Effects of Dipeptidyl Peptidase-4 Inhibitors on Renal Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis

BACKGROUND: To investigate the effects of dipeptidyl peptidase-4 (DPP-4) inhibitors on renal outcomes in patients with type 2 diabetes. METHODS: MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials were searched to identify randomized controlled trials (RCTs) of DPP-4 inhibitors f...

Descripción completa

Detalles Bibliográficos
Autores principales: Bae, Jae Hyun, Kim, Sunhee, Park, Eun-Gee, Kim, Sin Gon, Hahn, Seokyung, Kim, Nam Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435854/
https://www.ncbi.nlm.nih.gov/pubmed/30912341
http://dx.doi.org/10.3803/EnM.2019.34.1.80

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435854/
https://www.ncbi.nlm.nih.gov/pubmed/30912341
http://dx.doi.org/10.3803/EnM.2019.34.1.80

Ejemplares similares